Gamida Cell Ltd
NASDAQ:GMDA
Gamida Cell Ltd
NASDAQ:GMDA
Price:
0.0165 USD
8.55%
Market Closed
Updated:
May 17, 2024
Gamida Cell Ltd
Selling, General & Administrative
|
Gamida Cell Ltd
Selling, General & Administrative Peer Comparison
Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gamida Cell Ltd
NASDAQ:GMDA
|
Selling, General & Administrative
-$44.6m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Selling, General & Administrative
-$6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Selling, General & Administrative
-$29.5m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-11%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Selling, General & Administrative
-$93.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Selling, General & Administrative
-$4.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Selling, General & Administrative
-₪11.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
See Also
What is Gamida Cell Ltd's Selling, General & Administrative?
Selling, General & Administrative
-44.6m
USD
-44.6m
USD
Based on the financial report for Dec 31, 2023, Gamida Cell Ltd's Selling, General & Administrative amounts to -44.6m USD.
What is Gamida Cell Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-31%
-31%
Over the last year, the Selling, General & Administrative growth was -115%. The average annual Selling, General & Administrative growth rates for Gamida Cell Ltd have been -49% over the past three years , -31% over the past five years .
You don't have any saved screeners yet
